Related Experiment Videos
Hypereosinophilic syndrome: case presentation and update
Kristin M Leiferman1, Gerald J Gleich
1Department of Dermatology, University of Utah, Salt Lake City, Utah 84132-2409, USA.
The Journal of Allergy and Clinical Immunology
|January 10, 2004
Summary
Persistent peripheral blood eosinophilia, a condition linked to various diseases, can manifest as severe mucosal ulcers. This presentation may indicate a specific mutation in hypereosinophilic syndrome (HES) responsive to imatinib mesylate treatment.
Area of Science:
- Hematology
- Immunology
- Gastroenterology
Background:
- Persistent peripheral blood eosinophilia is linked to diverse conditions, including parasitic infections, gastrointestinal disorders, vasculitis, and hypereosinophilic syndrome (HES).
- Mucosal ulcerations represent a variant presentation of HES, potentially marking a specific patient subgroup.
Observation:
- A patient presented with peripheral blood eosinophilia and severe, recurrent mucosal ulcers.
- This presentation suggests a potential link between eosinophilia, mucosal ulcerations, and a treatable HES subtype.
Findings:
- Mucosal ulcerations in HES may serve as markers for a mutation.
- This mutation is associated with responsiveness to imatinib mesylate therapy.
Implications:
- Identifying this HES subgroup can guide targeted treatment strategies.
- Early recognition of eosinophilia with mucosal ulcerations may lead to prompt and effective intervention with imatinib mesylate.
- Further research into HES variants and their molecular underpinnings is crucial for advancing patient care.